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ABSTRACT
Objectives: Holt-Oram syndrome manifests with defects of upper limbs, pectoral girdle and cardiovascular system. The 
aim of this paper was to present complex clinical picture of the syndrome and its variable expression on the example of 
the family diagnosed genetically on the neonatal ward, after proband’s prenatal examination.
Maretial and methods: Nine family members were tested for TBX5 gene mutation.
Results: Four of family members were diagnosed with Holt-Oram syndrome and five had correct genetic test results. The 
diagnosis allowed to identify a genetic risk family and enabled to provide them with genetic counselling.
Conclusions: Diagnosis of Holt-Oram syndrome is possible as early as in prenatal period and it can be verified by genetic tests.
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INTRODUCTION
Holt-Oram syndrome (HOS, OMIM 142900) is a genetic 
disease with autosomal dominant inheriting pattern. The 
estimated frequency of HOS is 1/100 000 births [1]. Syn-
drome is caused by loss-of-function mutations of TBX5 gene 
localized on the long arm of chromosome 12 (12q24.1) 
[2]. Clinical picture is very diversified. Dominant symptoms 
include defects of upper limbs and cardiovascular system. 
Diagnosis of Holt-Oram syndrome is possible through recog-
nizing characteristic spectrum of defects prenatally, which 
has got a great meaning. It enables to plan appropriate time 
and place for labour to minimize the risk of complications [3, 
4], especially in case of heart defects, which can be severe. 
Verification of diagnosis by molecular tests can be followed 
by genetic counselling concerning evaluation of the risk of 
repeating the defect in the family, which is an important ele-
ment of primary prevention [5]. Patients with the syndrome 
aren’t always directed to genetic counselling.
OBJECTIVES
The aim of the study is to present a clinical picture of 
Holt-Oram syndrome and variability of its clinical expression, 
as well as possibility of diagnosing it prenatally and verifying 
by molecular tests.
The study describes family members with various clinical 
symptoms suggesting Holt-Oram syndrome. They weren’t 
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diagnosed until prenatal genetic consultation, which took 
place after coexistence of limbs reduction defects and con-
genital heart disorders was observed. Analysis of family 
tree and conducted molecular tests allowed to diagnose 
syndrome among the family members (Fig. 1).
MATERIAL AND METHODS
Study included nine family members, who agreed 
to draw the blood sample. Four of them had Holt-Oram 
syndrome-suggesting clinical symptoms. Genetic material 
analysis and genetic counselling took place in Department 
of Medical Genetics of Poznan University of Medical Sci-
ences. Tests were conducted as part of a science project 
financed by The National Science Centre ‘Accurate and exact 
CNV identification from targeted high-throughput sequence 
data in patients with congenital bilateral limb defects’ (Nr: 
UMO-2011/03/D/NZ2/06136).
Proband
Female neonate born in 37th week of first pregnancy 
through caesarean section indicated by congenital fetus 
defect. Neonate’s body mass was 2540 grams (> 10 c.), head 
circumference 32 cm (10 c.), body length 51 cm (90 c.). Apgar 
score was 7 points in first and 8 points in fifth minute of life. 
In physical examination and X-ray congenital upper limb 
defects with significant shortening were observed (Fig. 2). 
On the right three metacarpal bones, three phalanges and 
lack of forearm bones can be seen. Left limb consists of 
metacarpal bones and shortened humerus, but there are no 
forearm bones and phalanges. These defects were described 
in prenatal assessment. Considering syndrome associated 
cardiovascular disorders and the presence of heart murmur, 
case was consulted by cardiologist, who diagnosed atrial 
septal defect and patent ductus arteriosus, which is a regu-
larity in this gestational age. In 6 weeks echocardiography 
was performed and the results were correct. During patient’s 
stay in neonatal ward cranial and abdominal ultrasound was 
carried out with no deflections from physiology. Otoacoustic 
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Figure 1. Pedigree structures of Holt-Oram Syndrome. Molecular tests were conducted in 9 numbered cases
Figure 2. Upper limb defects with shortening. On the right upper 
limb three metacarpal bones, three phalanges and lack of forearm 
are observed. Left limb consists of metacarpal bones and shortened 
humerus, no forearm bones and phalanges
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emissions test result was correct. Neonate was breastfed and 
appropriately gained weight.
Proband’s mother
Mother at the age of 27 with upper limb phocomelia 
of significant degree: three fingers, lack of thumb, limb’s 
lenght: 23 cm. She also suffers from heart arrhythmia. Patient 
took vitamins through pregnancy which proceeded without 
severe problems. Proband’s mother went through urinary 
tract infection treated by Duomox. She worked as a security 
guard during pregnancy. At the age of 18 she underwent 
a right hip joint replacement.
Family members
Other seven family members were examined and the 
symptoms were present in various intensities (Fig. 1). The 
study group along with proband and proband’s mother 
consisted of five women and four men. Four of them had 
incorrect results of genetic test.
Molecular tests
After receiving consent on running tests, venous blood 
samples (with EDTA) were taken from all patients (neonate, 
mother and other seven family members). DNA isolation 
was conducted by salting out protein considering standard 
protocol. Proband had coding sequence of TBX5 gene (MIM 
ID*601620; GenBank NM_000192) analysis by Sanger’s se-
quencing method, intragenic rearrangement examination of 
TBX5, SALL4 i SALL1 by multiplex ligation-dependent probe 
amplification (MLPA) using P180-B1kit (MRC-Holland). Array 
comparative genomic hybridization (array CGH), resolution 
of 1,4 billion per haploid genome (Roche-NimbleGen) was 
performed for precise detection of deletion range. To inves-
tigate if proband’s deletion is segregated with phenotype, 
the rest of the family had MLPA examination.
RESULTS 
Heterozygous deletion of whole coding sequence of 
TBX5 gene was detected in neonate’s and mother’s genomes 
by MLPA method, which confirmed diagnosis of Holt-Oram 
syndrome. Results of previously conducted sequencing 
of particular exons of TBX5 proband’s gene excluded the 
presence of point mutation. Deletion of TBX5 included all 
exons of the gene, so additional array CGH was conducted 
to verify if no adjacent gene was deleted. Test confirmed 
that deletion of TBX5 gene was selective (deletion size 
87,1 kb; genome coordinates by HG19 — chr12:114797295-
114884394). MLPA method detected identical deletion 
in genome of two other family members. No abnormali-
ties were observed in five patients without clinical symp-
toms. All examined patients received genetic counselling, 
considering diagnosed disease and risk of passing it to their 
children. In general: nine patients were tested, four were 
diagnosed with Holt-Oram syndrome and five had correct 
test results (Fig. 3).
DISCUSSION
Holt-Oram Syndrom was described for the first time in 
1960 by Mary Holt and Samuel Oram [6]. It manifests with 
wide spectrum of defects of upper limbs and cardiovascular 
system. It is inherited by autosomal dominant pattern, 74% 
of patients who strictly fulfill the diagnostic criteria, have 
a mutation in TBX5 gene ascertained [7]. By other authors 
TBX5 mutations are identified only among around 30% of 
Figure 3. Proband had coding sequence of TBX5 gene (MIM ID*601620; GenBank NM_000192) analysis by Sanger’s sequencing method, intragenic 
rearrangement examination of TBX5, SALL4 i SALL1 by multiplex ligation-dependent probe amplification (MLPA) using P180-B1kit (MRC-Holland). 
Array comparative genomic hybridization (array CGH), resolution of 1,4 billion per haploid genome (Roche-NimbleGen) was performed. Test 
confirmed selective deletion of TBX5 gene (deletion size 87,1 kb; genome coordinates by HG19 — chr12:114797295- 114884394)
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patients [8]. Mentioned differences are a result of various 
HOS diagnostic criteria and patients’ qualification to mo-
lecular tests. Most of cases occur among family members 
(around 60%), whereas around 40% are results of de novo 
mutations [1].
Defects of upper limbs such as: thumb’s, clavicle’s and 
scapula’s deformations, syndactyly and clinodactyly may 
not have influence on patient’s functioning. Although, as 
it happened to our patients, major defects of upper limbs 
such as phocomelia (10% of cases) are being observed [9]. 
The defects may be unilateral or bilateral, however radius 
is always affected. In majority of cases the disturbances are 
observed on the left side of the body [10]. Around 75% of 
patients with HOS are also affected with cardiovascular 
disorders [11, 12]. Most common are atrial septal defect, ven-
tricular septal defect or stenosis of pulmonary vessels [1, 10, 
13]. Beside congenital heart diseases, various arrhythmias 
including conduction block, are observed [14]. Conduction 
defects are described independently of congenital heart 
diseases, as it happened in proband’s mother case.
In so far as prognosis for patients with HOS is mainly 
connected with cardiovascular disturbances [15], the defects 
in skeletal system have got the major impact on patient’s 
functioning. Although there is a possibility of substitution 
with a prosthesis, it’s a very expensive treatment and does 
not always allow patients’ independency. Genetic tests and 
counseling given to parents after taking their results, may 
ease making of conscious decision on reproduction. It’s 
an essential part of primary prevention [15].
Prenatal diagnosis is possible even before 14th week of 
pregnancy and should not cause difficulties, especially if 
major limb reductions occur [16]. Notice of abnormalities 
in cardiovascular system and in upper limbs needs to be 
differentiated with trisomy 13, 18 and others heart-hand 
syndromes, brachydactyly and long-thumb syndromes, dis-
turbances connected with SALL4 gene mutations (Okihiro 
syndrome), Fanconi anemia, TAR (thrombocytopenia and 
absent radius) syndrome, some cases of VACTERL associa-
tion or 22q11.2 deletion, 5q35.2-q35.3microduplications or 
embryopathies [17, 18]. 
Prenatal diagnostics play an important role in neonatol-
ogy. Early prenatal identification of congenital defects allows 
to adequately plan date and place of labor, so the neonate 
can be given fast and specialist perinatal care. Coexisting 
of mother’s and neonate’s congenital defects obligate to 
diagnostic enhancement among family members, who had 
similar abnormalities. During taking family history it tran-
spired that cardiovascular and limbs disorders, which sug-
gested the diagnosis of Holt-Oram syndrom in both patients 
(proband and its mother), was noticed among other family 
members. They mainly affected various abnormalities in 
cardiovascular system and upper limbs morphology. Some 
family members had no HOS symptoms, but were afraid of 
carrying the defect and passing it to their children. Detailed 
medical history with few family members was taken and 
genetic tests were proposed to enable genetic consulting, 
which may help to make reproductive decisions. Patients 
with HOS have various clinical picture — may require per-
manent help or function well, depending on severity of 
defects. Some defects may be lethal [1].
As the case of the family shows, despite of symptoms of 
genetic disease among family members, genetic counselling 
nor genetic tests were offered. It’s a proof of significance of 
prenatal diagnosis in identifying families with congenital 
diseases risk. It’s also an example of a proper cooperation 
of neonatologists and dispensaries or genetic laboratories 
as neonatologists are the first doctors to diagnose neo-
nates with congenital defect syndromes and families with 
genetic risk.
Considering variable clinical expression of Holt-Oram 
syndrome, even within one family, as seen in Table 1, pheno-
type prediction on the basis of genetic test result, TBX5 mu-
tation, is not possible. This gene codes T-box5 protein that is 
a transcription factor regulating expression of other genes 
responsible for development of heart and limbs. It is well 
known that missense mutations in T-Box5 5’ end, which 
connects with major groove of targeted DNA sequence, 
are associated with more severe heart defects. Missense 
mutations in 3’ end, that connects with minor groove, are 
linked to more serious limb defects [11, 19].
Family’s genetic tests have showed deletion of whole 
TBX5 gene. It’s an aberration present in about 2% of patients 
with existing HOS symptoms, which didn’t have frequent 
point mutations detected (up to 70% of patients that fulfil 
strict HOS criteria) [7]. This kind of deletion currently isn’t 
correlated with specific HOS phenotype.
Diagnosis of the syndrome permits to focus prophylactic 
care on the affected patients. Recommendations for people 
with Holt-Oram syndrome refer:
 Ū ECG once a year (or more often in case of patients with 
conduction disorders or in a group of risk; alternately 
with Holter monitor);
 Ū UCG once one to five years (depending on the morpho-
logical heart defect).
CONCLUSIONS
As presented in this study, Holt-Oram syndrome includes 
wide spectrum of upper limbs and pectoral girdle defects, 
as well as morphological and physiological disorders of 
cardiovascular system. Diagnosis of the syndrome is pos-
sible as early as in prenatal period and it can be verified by 
genetic tests. HOS should be considered in all cases of fetus’ 
limb reduction defects, especially if coexisting with septal 
heart defects or cardiac conduction disorders.
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